Minnesota · 2025-2026 Regular Session · Bill
SF 4189: Commissioner of health direction to study and report on activities to support innovations in cell and gene therapy to treat rare diseases
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SF 4189 is a bill introduced in the Minnesota Senate on March 5, 2026. According to its official title, it concerns: Commissioner of health direction to study and report on activities to support innovations in cell and gene therapy to treat rare diseases. Primary sponsor: Julia Coleman (Republican). It lists 4 additional sponsors. Most recent recorded action (April 7, 2026): Author added Miller.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic-Farmer-Labor 2 · Republican 3
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Julia Coleman | Primary sponsor | Republican | Senate | 48 |
| Liz Boldon | Co-sponsor | Democratic-Farmer-Labor | Senate | 25 |
| Amanda Hemmingsen-Jaeger | Co-sponsor | Democratic-Farmer-Labor | Senate | 47 |
| Jeremy Miller | Co-sponsor | Republican | Senate | 26 |
| Jordan Rasmusson | Co-sponsor | Republican | Senate | 9 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Author added Miller
- Author added Hemmingsen-Jaeger
- Author added Rasmusson
- Referred to Health and Human Services
- Introduction and first reading